The association of helicobacter pylori eradication with the occurrences of chronic kidney diseases in patients with peptic ulcer diseases

PLoS ONE

Volumn 11, Issue 10, 2016, Pages

  Wang, Jiunn Wei ^a   Hsu, Chien Ning ^b,c   Tai, Wei Chen ^b,d   Ku, Ming Kun ^e,f   Tseng, Kuo Lun ^a   Yuan, Lan Ting ^g   Nguang, Seng Howe ^h   Liang, Chih Ming ^b   Yang, Shih Cheng ^b   Wu, Cheng Kun ^b   Hsu, Pin I ⁱ   Wu, Deng Chyang ^a   Chuah, Seng Kee ^b,d  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^e FOOYIN UNIVERSITY HOSPITAL   (Taiwan)

^f Buddist Tzu Chi General Hospital Dalin Branch   (Taiwan)

^g YUAN'S GENERAL HOSPITAL   (Taiwan)

^h PINGTUNG CHRISTIAN HOSPITAL   (Taiwan)

ⁱ NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIHISTAMINIC AGENT; CLARITHROMYCIN; METRONIDAZOLE; PROTON PUMP INHIBITOR; TETRACYCLINE; ANTIINFECTIVE AGENT;

ACUTE KIDNEY FAILURE; ADULT; AGE; AGED; ARTICLE; BACTERIAL CLEARANCE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; HELICOBACTER PYLORI; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; PEPTIC ULCER; POPULATION RESEARCH; RISK FACTOR; SCREENING TEST; COMBINATION DRUG THERAPY; COMPLICATION; DIABETES COMPLICATIONS; FACTUAL DATABASE; HELICOBACTER INFECTIONS; MICROBIOLOGY; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; RENAL INSUFFICIENCY, CHRONIC; TAIWAN;

ADULT; AGE FACTORS; AGED; ANTI-BACTERIAL AGENTS; COHORT STUDIES; CONNECTIVE TISSUE DISEASES; DATABASES, FACTUAL; DIABETES COMPLICATIONS; DRUG THERAPY, COMBINATION; FEMALE; HELICOBACTER INFECTIONS; HUMANS; LUNG DISEASES; MALE; MIDDLE AGED; PEPTIC ULCER; PROPORTIONAL HAZARDS MODELS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TAIWAN;

EID: 84992323879     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0164824     Document Type: Article

References (30)

1. Marshall BJ, Warren JR. (1984) Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1: 1311-1315. PMID: 6145023
2. Khedmat H, Taheri S. (2009) Current knowledge on Helicobacter pylori Infection in end stage renal disease patients. Saudi J Kidney Dis Transpl 20: 969-974. PMID: 19861855
3. Rocha GA, Queiroz DM, Mendes EN, Oliveira AM, Moura SB, Barbosa MT, et al. (1992) Indirect immunofluorescence determination of the frequency of anti-H. pylori antibodies in Brazilian blood donors. Braz J Med Biol Res 25: 683-689. PMID: 1342599
4. Perez-Perez GI, Taylor DN, Bodhidatta L, Wongsrichanalai J, Baze WB, Dunn BE, et al. (1990) Seroprevalence of Helicobacter pylori infections in Thailand. J Infect Dis 161: 1237-1241. PMID: 2345304
5. Sugimoto M, Yamaoka Y. (2010) Review of Helicobacter pylori infection and chronic renal failure. Ther Apher Dial 15: 1-9. doi: 10.1111/j.1744-9987.2010.00851.x PMID: 21272246
6. Uemura N, Okamoto S, Yamamoto S, Matsumura N, Yamaguchi S, Yamakido M, et al. (2001) Helicobacter pylori infection and the development of gastric cancer. N Engl J Med 345: 784-789. doi: 10. 1056/NEJMoa001999 PMID: 11556297
7. Gasbarrini A, Franceschi F, Tartaglione R, Landolfi R, Pola P, Gasbarrini G. (1998) Regression of autoimmune thrombocytopenia after eradication of Helicobacter pylori. Lancet 352: 878.
8. Tebbe B, Geilen CC, Schulzke JD, Bojarski C, Radenhausen M, Orfanos CE. (1996) Helicobacter pylori infection and chronic urticaria. J Am Acad Dermatol 34: 685-686. PMID: 8601663
9. Annibale B, Marignani M, Monarca B, Antonelli G, Marcheggiano A, Martino G, et al. (1999) Reversal of iron deficiency anemia after Helicobacter pylori eradication in patients with asymptomatic gastritis. Ann Intern Med 131: 668-672. PMID: 10577329
10. Franceschi F, Zuccalà G, Roccarina D, Gasbarrini A. (2014) Clinical effects of Helicobacter pylori outside the stomach. Nat Rev Gastroenterol Hepatol 11: 234-242. doi: 10.1038/nrgastro.2013.243 PMID: 24345888
11. Niccoli G, Franceschi F, Cosentino N, Giupponi B, De Marco G, Merra G, et al. (2010) Coronary atherosclerotic burden in patients with infection by CagA-positive strains of Helicobacter pylori. Coron Artery Dis 21: 217-221. doi: 10.1097/MCA.0b013e3283399f36 PMID: 20389238
12. Shih HY KF, Wang SS. (2013) Helicobacter pylori infection and anemia in Taiwanese adults. Gastroenterol Res Pract 2013: doi: 10.1155/2013/390967 PMID: 24348534
13. Lin SY, Lin CL, Liu JH, Yang YF, Huang CC, Kao CH. (2015) Association between Helicobacter pylori infection and the subsequent risk of end-stage renal disease: a nationwide population-based cohort study. Int J Clin Pract 69: 604-610. doi: 10.1111/ijcp.12602 PMID: 25644865
14. National health insurance research database, NHRI. Available: http://nhird.nhri.org.tw/en/index.htm. Accessed 30 July 2015.
15. Deyo RA, Cherkin DC, Ciol MA. (1992) Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 45: 613-619. PMID: 1607900
16. Hiew C, Duggan A, de Malmanche T, Hatton R, Baker F, Attia J, et al (2012) Prevalence of Helicobacter pylori positivity in patients undergoing percutaneous coronary intervention. Intern Med J 42: 289-93. doi: 10.1111/j.1445-5994.2010.02260.x PMID: 20492005
17. Nozaki K, Shimizu N, Ikehara Y, Inoue M, Tsukamoto T, Inada K, et al. (2003) Effect of early eradication on Helicobacter pylori-related gastric carcinogenesis in Mongolian gerbils. Cancer Sci 94: 235-9. PMID: 12824915
18. Kurata JH, Nogawa AN. (1997) Meta-analysis of risk factors for peptic ulcer: Nonsteroidal antiinflammatory drugs, Helicobacter pylori, and smoking. J Clinic Gastroenterol 24: 2-17.
19. Wu CY, Wu MS, Chen YJ, Wang CB, Lin JT. (2009) Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease. Gastroenterology 137: 1641-1678. doi: 10. 1053/j.gastro.2009.07.060 PMID: 19664631
20. Satoh M. (2012) Endothelial dysfunction as an underlying pathophysiological condition of chronic kidney disease. Clin Exp Nephrol 16: 518-521. doi: 10.1007/s10157-012-0646-y PMID: 22669535
21. Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, Higashi Y, et al. (2005) Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol 45: 1219-1222. doi: 10.1016/j.jacc.2005.01.019 PMID: 15837252
22. Grabczewska Z, Nartowicz E, Kubica J, Rość D. (2006) Endothelial function parameters in patients with unstable angina and infection with Helicobacter pylori and Chlamydia pneumoniae. Eur J Intern Med 17: 339-342. doi: 10.1016/j.ejim.2006.02.005 PMID: 16864009
23. Marra M, Bonfigli AR, Bonazzi P, Galeazzi R, Sirolla C, Testa I, et al. (2005) Asymptomatic Helicobacter pylori infection increases asymmetric dimethylarginine levels in healthy subjects. Helicobacter 10: 609-614. doi: 10.1111/j.1523-5378.2005.00359.x PMID: 16302987
24. Mihout F, Shweke N, Bigé N, Jouanneau C, Dussaule JC, Ronco P, et al. (2011) Asymmetric dimethylarginine (ADMA) induces chronic kidney disease through a mechanism involving collagen and TGF- β1 synthesis. J Pathol 223: 37-45. doi: 10.1002/path.2769 PMID: 20845411
25. Chen CY, Liao KM. (2016) Chronic obstructive pulmonary disease is associated with risk of chronic kidney disease: A nationwide case-cohort study. Sci Rep 11: 25855.
26. Chiu HY, Huang HL, Li CH, Chen HA, Yeh CL, Chiu SH, et al. (2015) Increased risk of chronic kidney disease in rheumatoid arthritis associated with cardiovascular complications - A national populationbased cohort study. PLoS One 10: e0136508. doi: 10.1371/journal.pone.0136508 PMID: 26406879
27. Hsu PI, Lai KH, Lin CK, Chen WC, Yu HC, Cheng JS, et al. (2005) A prospective randomized trial of esomeprazole- versus pantoprazole-based triple therapy for Helicobacter pylori eradication. Am J Gastroenterol 100: 2387-2392. doi: 10.1111/j.1572-0241.2005.00264.x PMID: 16279889
28. Chuah SK, Tsay FW, Hsu PI, Wu DC. (2011) A new look at anti-Helicobacter pylori therapy. World J Gastroenterol 17: 3971-3975. doi: 10.3748/wjg.v17.i35.3971 PMID: 22046084
29. Tai WC, Liang CM, Lee CH, Chiu CH, Hu ML, Lu LS, et al. (2015) Seven-day non-bismuth containing quadruple therapy could achieve a grade "A" success rate for first-line Helicobacter pylori eradication. Biomed Res Int 2015; 623732.
30. Liou JM, Wu MS, Lin JT. (2016) Treatment of Helicobacter pylori infection-Where are we now? J Gastroenterol Hepatol 2016: doi: 10.1111/jgh.13418 PMID: 27088632